云南省傣药质量标准调研报告  

Survey on Quality Standard of Dai Medicine in Yunnan Province

作　　者：任李玥 台海川 张赟华 李忠琼 陈彬 张雯洁 

机构地区：[1]云南省食品药品检验所,昆明650000 [2]西双版纳傣族自治州食品药品检验所,景洪666100

出　　处：《中国药事》2015年第12期1286-1288,共3页Chinese Pharmaceutical Affairs

基　　金：国家食品药品监督管理总局药化注册司专项"九省区民族药质量标准现状调研与分析"

摘　　要：目的:通过对西双版纳傣药现状的调查,发掘傣药质量标准存在的主要问题,为卫生行政部门提供有价值的数据,为促进傣药的进一步发展提供建议。方法:对21个生产企业的88个傣药品种进行调研,对这些药材的执行标准情况进行分析。结果:在制订傣药质量标准中,标准物质缺乏成为药材质量不能得到有效控制的瓶颈。结论:傣药具有广阔的开发前景,然而质量标准的不健全限制了傣药的发展。建议地方和国家加大对傣药的重视,增强经费投入,加强人才培养,尽快完善和健全傣药的质量标准。Objective： To conduct the survey of Dai medicine in Xishuangbanna, so as to find out main problems in the quality standard of Dai medicine, provide useful information for the health administration, and propose suggestions for the further development of Dai medicine. Methods： The survey was conducted on 88 kinds of Dai medicine belonging to 21 manufacturers, and the implementation status of quality standard was analyzed. Results：Lack of standard substance is the main bottleneck of quality standard for Dai medicine, resulting in that the quality of drugs could not be controlled properly. Conclusion： Dai medicine has great prospect of development, however, unsoundness of the quality standard limits the development of Dai medicine. It is suggested that local and national governments should pay more attention on ethnic medicine, increase fund investment, bring up more professionals and improve the quality standard for ethnic medicine as soon as possible.

关 键 词：民族药调研 傣药 药物标准 

分 类 号：R931[医药卫生—生药学] R932[医药卫生—药学]